Skip to main content
. 2021 Aug 27;13(17):4328. doi: 10.3390/cancers13174328

Figure 2.

Figure 2

Functional impact of chimeric RNAs in cancer heterogeneity and drug resistance: (a) functional model for chimeric RNAs generated at the early stage of cancers; (b) functional model for chimeric RNAs generated at the later stage of cancers.